5353985
Last Update Posted: 2025-08-20
Recruiting has ended
All Genders accepted | 12 Years + |
153 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
Eligibility
Relevant conditions:
Celiac Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Takeda Contact
medinfoUS@takeda.com
+1-877-825-3327
Data sourced from ClinicalTrials.gov